BerandaBEAM • BMV
add
Beam Therapeutics Inc
Tutup sebelumnya
$332,69
Rentang tahun
$299,80 - $696,15
Kapitalisasi pasar
1,69Â M USD
Volume Rata-Rata
16,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 7,47Â jt | 0,81% |
Biaya operasional | 111,02Â jt | 18,24% |
Laba bersih | -109,27Â jt | -10,74% |
Margin laba bersih | -1,46Â rb | -9,85% |
Penghasilan per saham | -1,24 | -2,48% |
EBITDA | -113,76Â jt | -15,26% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,22Â M | 11,46% |
Total aset | 1,47Â M | 7,88% |
Total liabilitas | 343,78Â jt | -22,97% |
Total ekuitas | 1,12 M | — |
Saham yang beredar | 97,49 jt | — |
Harga terhadap nilai buku | 28,88 | — |
Tingkat pengembalian aset | -23,20% | — |
Tingkat pengembalian modal | -27,41% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -109,27Â jt | -10,74% |
Kas dari operasi | -103,88Â jt | -4,15% |
Kas dari investasi | -125,09Â jt | -133,97% |
Kas dari pembiayaan | 473,38Â jt | 16.240,32% |
Perubahan kas bersih | 244,41Â jt | 262,60% |
Arus kas bebas | -85,92Â jt | -51,95% |
Tentang
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods. Wikipedia
CEO
Didirikan
2017
Situs
Karyawan
393
